CN Stock MarketDetailed Quotes

688606 Hangzhou Alltest Biotech

Watchlist
  • 65.25
  • +1.24+1.94%
Market Closed May 12 15:00 CST
5.17BMarket Cap16.22P/E (TTM)

About Hangzhou Alltest Biotech Company

Established in 2014, the company is a high-tech enterprise certified by the National Science and Technology Agency. It has strong technical research and innovation capabilities, and has strong technical strength in research in biological fields such as colloidal gold and latex labeling technology, monoclonal antibodies, polyclonal antibodies, recombinant antigens, synthetic antigens, etc., and immunochromatography technology. The company's main business is R&D, production and sales of in vitro rapid diagnostic reagents. The company's main products: POCT rapid diagnostic test reagent (colloidal gold), time-resolved immunofluorescence detection reagent, biochemical diagnostic test reagent, chemiluminescence detection reagent, biological raw material series, immunoblotting series, electronic instrument series, biosensing electrochemistry series, molecular diagnostic series. Corporate honors: Zhejiang Province Top 500 High-tech Enterprises with Innovative Capabilities, China's Top 50 Medical Device Companies, Hangzhou Top 100 Manufacturing Enterprises, Hangzhou Digital Service Trade Top 100 Enterprises, China's First Batch of “1000 Enterprises, 100 Cities” Trademark Brand Value Enhancement Action Enterprises, Hangzhou Enterprise Technology Center, High-tech Enterprise, Hangzhou Enterprise High-tech R&D Center (Industrial), Hangzhou “Three-Star” Headquarters Enterprise, “Hangzhou Listed Enterprise ESG Strategy Charity Influence Pioneer 20”, “2024 China A-share Listed Companies Growth Power Company of the Year” ”, “Zhejiang Clean Private Enterprise Construction Model 2024”, Zhejiang Top 500 High-tech Enterprise Innovation Capability Enterprises in 2024, Zhejiang Enterprise Research Institute, etc.

Company Profile

Short Name-A奥泰生物
Company NameHangzhou Alltest Biotech Co., Ltd.
Listing DateMar 25, 2021
Issue Price133.67
Shares Offered13.50M share(s)
FoundedApr 17, 2009
Chairmanfei gao
Legal Representativefei gao
General Managerfei gao
Secretaryyanping fu
Employees969
ProvinceZhe Jiang Sheng
Phone0571-56207860
Office AddressNo. 383, Qiaoxin Road, Xiasha Street, Qiantang District, Hangzhou, Zhejiang
Zip Code310018
Registered AddressBuilding 5, Building 3, Building 4, No. 550, Yinhai Street, Baiyang Street, Hangzhou Economic and Technological Development Zone, Jianggan District, Hangzhou City, Zhejiang Province
Fax0571-56267856
Emailinfo@alltests.com.cn
Business License91330101685842840Y
BusinessThe company focuses on the POCT segment in the in vitro diagnostic industry, and its main business is R&D, production and sales of in vitro diagnostic reagents.

Company Executives

  • Name
  • Position
  • Salary
  • fei gao
  • Chairman, Directors, General Manager, Core Technical Personnel
  • 1.15M
  • huafang zhao
  • Directors
  • --
  • weike lu
  • Directors, Deputy General Manager, Core Technical Personnel
  • 883.60K
  • yali zhou
  • Independent Directors
  • 70.00K
  • zhanwang zheng
  • Independent Directors
  • 70.00K
  • yanping fu
  • Board Secretary, Head of Finance
  • 656.80K
  • haijie pan
  • Securities Affairs Representative
  • --
  • bo chen
  • Auditors
  • 129.20K
  • yuecan gao
  • Auditors
  • 283.90K
  • fenfen qian
  • Employee Supervisors
  • 207.20K

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More